West Pharmaceutical Services (WST) makes packaging components for injectable drugs and vaccines. After a sharp decline from pandemic-era peaks, the stock has rebounded 37% this year driven by strong GLP-1 demand, margin expansion, and new leadership, though current valuations at 42x 2026 earnings guidance remain elevated.